These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 8776578)
1. Cellular immune reactions in brain transplantation: effects of graft pooling and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease. Schwarz SC; Kupsch AR; Banati R; Oertel WH Glia; 1996 Jun; 17(2):103-20. PubMed ID: 8776578 [TBL] [Abstract][Full Text] [Related]
2. Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease. Schwarz SC; Sauer H; Oertel WH; Earl CD; Kupsch AR Exp Brain Res; 1997 Jun; 115(1):71-82. PubMed ID: 9224835 [TBL] [Abstract][Full Text] [Related]
4. Immune reactions following systemic immunization prior or subsequent to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats. Duan WM; Widner H; Frodl EM; Brundin P Neuroscience; 1995 Feb; 64(3):629-41. PubMed ID: 7715776 [TBL] [Abstract][Full Text] [Related]
5. Time-dependent expression of donor- and host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macro- and micrografts: comparison of two different grafting protocols. Brandis A; Kuder H; Knappe U; Jödicke A; Schönmayr R; Samii M; Walter GF; Nikkhah G Acta Neuropathol; 1998 Jan; 95(1):85-97. PubMed ID: 9452826 [TBL] [Abstract][Full Text] [Related]
6. Differential immune responses to fetal intracameral spinal cord and cortex cerebri grafts. Shinoda M; Giacobini M; Schmidt-Kastner R; Trok K; Olson L Exp Brain Res; 1996 Jul; 110(2):223-34. PubMed ID: 8836687 [TBL] [Abstract][Full Text] [Related]
7. Increased tyrosine hydroxylase expression accompanied by glial changes within the non-lesioned hemisphere in the 6-hydroxydopamine model of Parkinson's disease. Schlachetzki JC; Marxreiter F; Regensburger M; Kulinich A; Winner B; Winkler J Restor Neurol Neurosci; 2014; 32(4):447-62. PubMed ID: 24604006 [TBL] [Abstract][Full Text] [Related]
8. Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats. Duan WM; Westerman M; Flores T; Low WC Exp Neurol; 2001 Jan; 167(1):108-17. PubMed ID: 11161598 [TBL] [Abstract][Full Text] [Related]
9. Allografts of CNS tissue possess a blood-brain barrier: III. Neuropathological, methodological, and immunological considerations. Broadwell RD; Baker BJ; Ebert PS; Hickey WF Microsc Res Tech; 1994 Apr; 27(6):471-94. PubMed ID: 8012052 [TBL] [Abstract][Full Text] [Related]
10. Rat intrastriatal neural allografts challenged with skin allografts at different time points. Duan WM; Cameron RM; Brundin P; Widner H Exp Neurol; 1997 Nov; 148(1):334-47. PubMed ID: 9398476 [TBL] [Abstract][Full Text] [Related]
11. Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection. Larsson LC; Frielingsdorf H; Mirza B; Hansson SJ; Anderson P; Czech KA; Strandberg M; Widner H Exp Neurol; 2001 Nov; 172(1):100-14. PubMed ID: 11681844 [TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated silencing of HLA A2 suppressed acute rejection against human fibroblast xenografts in the striatum of 6-OHDA lesioned rats. Liang C; Xu Y; Zheng D; Sun X; Xu Q; Duan D J Neuroimmunol; 2016 Aug; 297():28-37. PubMed ID: 27397073 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival of mouse corpus callosum grafts in neonatal rat recipients, and the effect of host sensitization. Pollack IF; Lee LH; Zhou HF; Lund RD J Neurosci Res; 1992 Jan; 31(1):33-45. PubMed ID: 1613822 [TBL] [Abstract][Full Text] [Related]
14. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006 [TBL] [Abstract][Full Text] [Related]
15. Restoration of dopamine overflow and clearance from the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal mesencephalic grafts. Wang Y; Wang SD; Lin SZ; Liu JC J Pharmacol Exp Ther; 1994 Aug; 270(2):814-21. PubMed ID: 7915321 [TBL] [Abstract][Full Text] [Related]
16. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts. Shinoda M; Hoffer BJ; Olson L J Neural Transplant Plast; 1997; 6(2):83-96. PubMed ID: 9306240 [TBL] [Abstract][Full Text] [Related]
17. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Xue YQ; Zhao LR; Guo WP; Duan WM Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174 [TBL] [Abstract][Full Text] [Related]
18. Roscovitine, an experimental CDK5 inhibitor, causes delayed suppression of microglial, but not astroglial recruitment around intracerebral dopaminergic grafts. Tomov N; Surchev L; Wiedenmann C; Döbrössy M; Nikkhah G Exp Neurol; 2019 Aug; 318():135-144. PubMed ID: 31028828 [TBL] [Abstract][Full Text] [Related]
19. Human ventromesencephalic grafts restore dopamine release and clearance in hemiparkinsonian rats. Wang Y; Lin JC; Chiou AL; Liu JY; Liu JC; Zhou FC Exp Neurol; 1995 Dec; 136(2):98-106. PubMed ID: 7498419 [TBL] [Abstract][Full Text] [Related]
20. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Modo M; Rezaie P; Heuschling P; Patel S; Male DK; Hodges H Brain Res; 2002 Dec; 958(1):70-82. PubMed ID: 12468031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]